Epidemiology

Europe Deep Vein Thrombosis Market and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

Retrieved on: 
Monday, October 25, 2021

The "Europe Deep Vein Thrombosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Deep Vein Thrombosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Deep Vein Thrombosis Market and Competitive Landscape 2021, provides comprehensive insights into Deep Vein Thrombosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Deep Vein Thrombosis treatment options, Deep Vein Thrombosis late-stage clinical trials pipeline, Deep Vein Thrombosis prevalence by countries, Deep Vein Thrombosis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Deep Vein Thrombosis pipeline: Find out drugs in clinical trials for the treatment of Deep Vein Thrombosis by development phase 3, phase 2, by pharmacological class and company
    Deep Vein Thrombosis drugs: Identify key drugs marketed and prescribed for Deep Vein Thrombosis in the US, including trade name, molecule name, and company
    Deep Vein Thrombosis drugs sales: Find out the sales value for Deep Vein Thrombosis drugs by countries
    Deep Vein Thrombosis market valuations: Find out the market size for Deep Vein Thrombosis drugs in 2020 by countries.

Europe Glomerulonephritis Markets and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

Retrieved on: 
Monday, October 25, 2021

The "Europe Glomerulonephritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Glomerulonephritis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Glomerulonephritis Market and Competitive Landscape - 2021, provides comprehensive insights into Glomerulonephritis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Glomerulonephritis market size and drug sales.
  • This research covers the following - Glomerulonephritis treatment options, Glomerulonephritis late-stage clinical trials pipeline, Glomerulonephritis prevalence by countries, Glomerulonephritis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.

Global Macular Edema Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 25, 2021

The "Global Macular Edema Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Macular Edema Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Global Macular Edema Market and Competitive Landscape - 2021, provides comprehensive insights into Macular Edema pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Macular Edema treatment options, Macular Edema late-stage clinical trials pipeline, Macular Edema prevalence by countries, Macular Edema market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Macular Edema pipeline: Find out drugs in clinical trials for the treatment of Macular Edema by development phase 3, phase 2, by pharmacological class and company
    Macular Edema drugs: Identify key drugs marketed and prescribed for Macular Edema in the US, including trade name, molecule name, and company
    Macular Edema market valuations: Find out the market size for Macular Edema drugs in 2020 by countries.

Europe Chronic Myeloid Leukemia Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Monday, October 25, 2021

The "Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Chronic Myeloid Leukemia Market and Competitive Landscape - 2021, provides comprehensive insights into Chronic Myeloid Leukemia pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Chronic Myeloid Leukemia treatment options, Chronic Myeloid Leukemia late-stage clinical trials pipeline, Chronic Myeloid Leukemia prevalence by countries, Chronic Myeloid Leukemia market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Chronic Myeloid Leukemia pipeline: Find out drugs in clinical trials for the treatment of Chronic Myeloid Leukemia by development phase 3, phase 2, by pharmacological class and company
    Chronic Myeloid Leukemia drugs: Identify key drugs marketed and prescribed for Chronic Myeloid Leukemia in the US, including trade name, molecule name, and company
    Chronic Myeloid Leukemia drugs sales: Find out the sales value for Chronic Myeloid Leukemia drugs by countries
    Chronic Myeloid Leukemia market valuations: Find out the market size for Chronic Myeloid Leukemia drugs in 2020 by countries.

Europe Wet Age-Related Macular Degeneration Markets and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

Retrieved on: 
Monday, October 25, 2021

The "Europe Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Wet Age-Related Macular Degeneration Market and Competitive Landscape - 2021, provides comprehensive insights into Wet Age-Related Macular Degeneration pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Wet Age-Related Macular Degeneration treatment options, Wet Age-Related Macular Degeneration late-stage clinical trials pipeline, Wet Age-Related Macular Degeneration prevalence by countries, Wet Age-Related Macular Degeneration market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Wet Age-Related Macular Degeneration pipeline: Find out drugs in clinical trials for the treatment of Wet Age-Related Macular Degeneration by development phase 3, phase 2, by pharmacological class and company
    Wet Age-Related Macular Degeneration epidemiology: Find out the number of patients diagnosed (prevalence) with Wet Age-Related Macular Degeneration by countries
    Wet Age-Related Macular Degeneration drugs: Identify key drugs marketed and prescribed for Wet Age-Related Macular Degeneration in the US, including trade name, molecule name, and company
    Wet Age-Related Macular Degeneration drugs sales: Find out the sales value for Wet Age-Related Macular Degeneration drugs by countries
    Wet Age-Related Macular Degeneration market valuations: Find out the market size for Wet Age-Related Macular Degeneration drugs in 2020 by countries.

Europe Liver Cirrhosis Market and Competitive Landscape Report 2021-2026: Pipeline, Epidemiology, Valuations, Forecasts, Drug Sales, Drug Forecasts, and Market Shares - ResearchAndMarkets.com

Retrieved on: 
Friday, October 22, 2021

The "Europe Liver Cirrhosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Liver Cirrhosis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Liver Cirrhosis Market and Competitive Landscape - 2021, provides comprehensive insights into Liver Cirrhosis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Liver Cirrhosis treatment options, Liver Cirrhosis late-stage clinical trials pipeline, Liver Cirrhosis prevalence by countries, Liver Cirrhosis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Liver Cirrhosis pipeline: Find out drugs in clinical trials for the treatment of Liver Cirrhosis by development phase 3, phase 2, by pharmacological class and company
    Liver Cirrhosis drugs: Identify key drugs marketed and prescribed for Liver Cirrhosis in the US, including trade name, molecule name, and company
    Liver Cirrhosis market valuations: Find out the market size for Liver Cirrhosis drugs in 2020 by countries.

FDA Selects Aetion Evidence Platform® to Advance Regulatory Science and Innovation

Retrieved on: 
Thursday, October 21, 2021

NEW YORK, Oct. 21, 2021 /PRNewswire/ --Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation.

Key Points: 
  • NEW YORK, Oct. 21, 2021 /PRNewswire/ --Today, Aetion announces that it is expanding its relationship with the U.S. Food and Drug Administration (FDA) to use real-world evidence (RWE) to study COVID-19 interventions and advance regulatory science and innovation.
  • FDA and Aetion will use Aetion Evidence Platform (AEP), validated software that enables efficient, transparent, and reliable RWE research, to develop a framework and system of studies for the rapid assessment of COVID-19 inpatient medical products.
  • Aetion and FDA will build on learnings from the research collaboration announced in May 2020, in which FDA and Aetion explored the utility of RWD to advance the understanding of and response to COVID-19.
  • The Aetion Evidence Platform analyzes data from the real world to produce transparent, rapid, and scientifically validated answers on safety, effectiveness, and value.

OpGen Subsidiary Ares Genetics Launches AREScloud

Retrieved on: 
Thursday, October 21, 2021

(Nasdaq: OPGN, OpGen), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that its subsidiary Ares Genetics , which strives to become a leader in bacterial genomics and the AI-powered prediction of antimicrobial resistance (AMR), has commercially launched its AREScloud web application.

Key Points: 
  • (Nasdaq: OPGN, OpGen), a precision medicine company harnessing the power of molecular diagnostics and informatics to help combat infectious disease, today announced that its subsidiary Ares Genetics , which strives to become a leader in bacterial genomics and the AI-powered prediction of antimicrobial resistance (AMR), has commercially launched its AREScloud web application.
  • The performance of AREScloud bioinformatics pipelines for isolate WGS has been validated in several clinical studies.
  • OpGen, Inc. (Rockville, MD, USA) is a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat infectious disease.
  • This press release includes statements regarding the commercial launch of AREScloud, a web application aimed at accelerating the analysis of sequenced clinical isolates.

Europe Von Willebrand Disease Markets and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 21, 2021

The "Europe Von Willebrand Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Von Willebrand Disease Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Von Willebrand Disease Market and Competitive Landscape - 2021, provides comprehensive insights into Von Willebrand Disease pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research covers the following - Von Willebrand Disease treatment options, Von Willebrand Disease late-stage clinical trials pipeline, Von Willebrand Disease prevalence by countries, Von Willebrand Disease market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.
  • Von Willebrand Disease pipeline: Find out drugs in clinical trials for the treatment of Von Willebrand Disease by development phase 3, phase 2, by pharmacological class and company
    Von Willebrand Disease drugs: Identify key drugs marketed and prescribed for Von Willebrand Disease in the US, including trade name, molecule name, and company
    Von Willebrand Disease drugs sales: Find out the sales value for Von Willebrand Disease drugs by countries
    Von Willebrand Disease market valuations: Find out the market size for Von Willebrand Disease drugs in 2020 by countries.

Europe Uveitis Market and Competitive Landscape Report 2021: Pipeline, Epidemiology, Market Valuations, Drug Sales, Drug Forecasts, and Market Shares 2018-2026 - ResearchAndMarkets.com

Retrieved on: 
Thursday, October 21, 2021

The "Europe Uveitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Europe Uveitis Market and Competitive Landscape - 2021" report has been added to ResearchAndMarkets.com's offering.
  • Europe Uveitis Market and Competitive Landscape - 2021, provides comprehensive insights into Uveitis pipeline, epidemiology, market valuations, drug sales, market forecast, drug forecasts, and market shares.
  • This research analyzes and forecasts Uveitis market size and drug sales.
  • This research covers the following - Uveitis treatment options, Uveitis late-stage clinical trials pipeline, Uveitis prevalence by countries, Uveitis market size and forecast by countries, key market events and trends, drug sales and forecast by countries, and market shares by countries.